Francis Knuettel II - 02 Jul 2025 Form 4 Insider Report for Pelthos Therapeutics Inc. (CHRO)

Role
CFO, Treas & Secty
Signature
/s/ Francis Knuettel II
Issuer symbol
CHRO
Transactions as of
02 Jul 2025
Net transactions value
$0
Form type
4
Filing time
07 Jul 2025, 21:44:42 UTC
Previous filing
03 Jul 2025
Next filing
06 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Francis Knuettel II CFO, Treas & Secty C/O PELTHOS THERAPEUTICS INC., 4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM /s/ Francis Knuettel II 07 Jul 2025 0001433316

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTHS Restricted Stock Units Award +33,472 33,472 02 Jul 2025 Common Stock 33,472 $13.50 Direct F1
transaction PTHS Stock Option Award +102,000 +237% 145,074 02 Jul 2025 Common Stock 102,000 $13.50 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 33,472 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and in equal installments on a quarterly basis thereafter over a period of two (2) years.
F2 On July 2, 2025, the Reporting Person was granted stock options to purchase 102,000 shares of common stock at an exercise price of $13.50 per share, with the initial one third (1/3) of such shares vesting on July 2, 2026, and quarterly thereafter in equal installments over a period of two (2) years.
F3 The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.